BIO-COMET, Bioreactor-based, clinically oriented
manufacturing of engineered tissues, is a four-year
research project, which has been supported by the
European Union under its Seventh Framework
Programme, FP7, and has ended in November 2015.
The project aims at the development and pre-clinical
testing of a sensor-based bioreactor system for the
production of functional, autologous engineered grafts
with reproducible properties. The bioreactor-based
manufacturing paradigm has focused on cartilage repair.
To achieve these goals, BIO-COMET has brought together
internationally renowned leaders in the field of
regenerative medicine, from academic, clinical and
industrial research institutions.